Alnylam PharmaceuticalsALNY 
$274.950.18%24h
0.18%24h
Global rank529
Market cap$34.34B
Change 7d2.48%
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals ALNY Total Debt
ALNY Total Debt in 2022: $1.26B
According to Alnylam Pharmaceuticals latest financial reports the total debt is $1.26B, an decrease of -1.13% to 2022. At the end of 2022 company had $1.28B total debt. This figure represents the debts and financial obligations that Alnylam Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Alnylam Pharmaceuticals ALNY Total Debt History from 2023 to 2022
-
Value:-
ALNY Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $1.26B | -1.13% |
| 2022 | $1.28B | 33.57% |
| 2021 | $957.04M | 97.61% |
| 2020 | $484.32M | 75.39% |
| 2019 | $276.13M | 820.45% |
| 2018 | $30.00M | - |
View the Top Total Debt Stocks 
